Article Details

Rigel Pharmaceuticals' (NASDAQ:RIGL) Buy Rating Reiterated at Cantor Fitzgerald

Retrieved on: 2019-02-03 09:18:40

Tags for this article:

Click the tags to see associated articles and topics

Rigel Pharmaceuticals' (NASDAQ:RIGL) Buy Rating Reiterated at Cantor Fitzgerald. View article details on hiswai:

Excerpt

<div>Finally, <b>Sofinnova Ventures</b> Inc increased its holdings in shares of Rigel Pharmaceuticals by 43.5% in the 3rd quarter. <b>Sofinnova Ventures</b> Inc now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up